http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5508302-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-32 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-32 |
| filingDate | 1994-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1996-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_394b98a0b1217de1b0f7554c76c04228 |
| publicationDate | 1996-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5508302-A |
| titleOfInvention | Phospholipase A2 inhibitors |
| abstract | There are disclosed compounds of the formula: <IMAGE> wherein R1 is <IMAGE> X is O, or S; Y is O or NOR2; R2 is alkyl, alkenyl, phenyl, -CH2CO2R3, -CH2Ph, -CH2C6F5, or <IMAGE> R3 is hydrogen, alkyl, phenyl, or phenylalkyl; R4, R5, and R6 are each, independently, hydrogen, alkyl, -OH, alkoxy, -CO2R3, halogen, -NH2, alkylamino, dialkylamino, or -NO2; m=0-20; and n=0-10 or a pharmacologically acceptable salt thereof which are useful as anti-inflammatory agents. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005014158-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005239077-A1 |
| priorityDate | 1994-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 266.